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The equine herpesvirus 1 (EHV-1) EICP27 protein cooperates with either the immediate-early (IE) or the EICP0 protein to synergistically
trans-activate viral promoters. GST-pulldown and co-immunoprecipitation assays revealed that the EICP27 protein’s cooperation with the IE
or the EICP0 protein involves its physical interaction with these viral proteins. In the case of the IE–EICP27 protein interaction, IE residues
424 to 826 and EICP27 residues 41 to 206 harbor the interactive domains. Electrophoretic mobility shift assays (EMSA) suggested that the
EICP27 protein is not a sequence-specific DNA-binding protein as it fails to directly bind to the IE promoter, the early EICP27, EICP0, and
TK promoters, or the late gD and IR5 promoters. However, EMSA studies also showed that the interaction of the IE and EICP27 proteins
results in the recruitment of the EICP27 protein to representative early promoters. These results support our hypothesis that the EICP27
protein participates in the trans-activation of EHV-1 promoters, and suggest its presence within RNA polymerase II preinitiation complexes
that assemble at viral promoters.
D 2004 Elsevier Inc. All rights reserved.
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The sole immediate-early (IE) gene of equine herpesvirus
1 (EHV-1) encodes a spliced viral transcript that is translated
to a 1,487-aa (200 kDa) phosphoprotein (Grundy et al.,
1989; Harty et al., 1989). The IE protein performs two well-
described regulatory activities: (i) repression of its own
promoter and the late glycoprotein K promoter (Kim et al.,
1999; Smith et al., 1992), and (ii) trans-activation of EHV-1
early and late promoters and some heterologous promoters
(Buczynski et al., 1999; Smith et al., 1992, 1993). Recently,
the IE protein was demonstrated to trans-activate the EICP0
promoter that is repressed by an as-yet unidentified cellular0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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Medicine, 1 Gustave L Levy Place, New York, NY 10029, USA.DNA-binding protein that binds to a cis-negative regulatory
element (NRE; Kim et al., 2004). These findings suggest that
the IE protein can mediate the derepression of viral
promoters. Infections with the mutant virus KyADIE that
lacks the IE (IR1) gene demonstrated that IE gene expression
is essential for virus replication (Garko-Buczynski et al.,
1998). The block in virus replication presumably occurs
because RNA polymerase II preinitiation complexes inef-
fectively assemble at the core elements of EHV-1 early
promoters in the absence of the IE protein. Thus, the IE
protein trans-activates viral promoters by facilitating the
assembly of preinitiation complexes at viral promoters.
Indeed, our previous investigations revealed that the cellular
transcription factors TATA box-binding protein (S. K. Kim
and D. J. O’Callaghan, unpublished observations) and TFIIB
(Albrecht et al., 2003; Jang et al., 2001) are interactive
partners of the IE protein.
The IE protein possesses several domains that are
essential to its trans-activation function: (i) an acidic005) 74–87
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al., 1999; Harty and O’Callaghan, 1991; Smith et al.,
1994), the interactive partners of which have not been
elucidated, (ii) a serine-rich tract that binds to the cellular
EAP protein (Kim et al., 2001), (iii) a nuclear localization
signal (aa 963 to 970) that is comprised of nonpolar and
basic amino acids (Smith et al., 1995), and (iv) a WLQN
region (residues 422 to 597) that mediates the IE protein’s
binding to the consensus DNA sequence 5V-ATCGT-3V
(Kim et al., 1995). The location of this pentanucleotide
sequence relative to the transcription initiation site dictates
whether the IE protein trans-activates or trans-represses
promoters (Kim et al., 1995, 1999). For example, the IE
protein autorepresses its own promoter and represses the
late gK promoter because a consensus sequence of this
cis element is adjacent to the transcription initiation sites
of these promoters (Grundy et al., 1989; Kim et al.,
1999).
The EICP27 (UL5) gene is transcribed early in
infection to a 1.6-kb transcript that is translated to a
470-aa nuclear phosphoprotein that harbors an arginine-
rich nuclear localization signal (aa 176 to 185; Albrecht et
al., 2004; Zhao et al., 1992). Sequence alignment of the
EICP27 protein (51.4 kDa) indicated that this protein
shares limited homology with its Alphaherpesvirinae
counterparts in herpes simplex virus type 1 (32% with
the HSV-1 ICP27 protein) and varicella-zoster virus (18%
with the VZV IE4 protein) (Piette et al., 1995; Zhao et al.,
1992). Our previous studies demonstrated that this protein:
(i) independently stimulates reporter gene expression from
the IE and early EICP0 promoters (Albrecht et al., 2004;
Zhao et al., 1995); (ii) cooperates in a synergistic manner
with the IE protein to achieve maximal activation of EHV-
1 early and some late promoters (Smith et al., 1992,
1993); and (iii) potentiates the activation of EHV-1
promoters by the EICP0 protein (Bowles et al., 2000).
The direct interaction of EICP27 residues 124 to 220 with
TBP is one mechanism by which the EICP27 protein: (i)
contributes to the trans-activation of EHV-1 promoters by
the IE and EICP0 proteins, and (ii) independently
stimulates the IE and early EICP0 promoters (Albrecht
et al., 2004).
In this manuscript, we present evidence that the
contributions of the EICP27 protein to viral gene expres-
sion do not involve its direct binding to promoter
sequences. The cooperation between the EICP27 and IE
proteins involves their physical interactions, and the
sequences within these two regulatory proteins that mediate
this interaction were mapped. The interaction of the
EICP27 and IE proteins results in the recruitment of the
EICP27 protein to viral promoters, where it may influence
the regulatory properties of the IE protein. The data are
consistent with our hypothesis that the EICP27 protein is
incorporated into preinitiation complexes, where it may
stimulate transcription initiation and/or elongation by
cellular RNA polymerase II.Results
The EICP27 protein is not a sequence-specific DNA-binding
protein
Our recent studies demonstrated that the EICP27 protein
activates the IE promoter [802/+73, relative to the
transcription initiation site] and the EICP0 promoter
[277/50, relative of the ATG start codon] that controlled
expression of the chloramphenicol acetyl-transferase (CAT)
reporter gene (Albrecht et al., 2004). It was of interest to
ascertain whether the activation of these viral promoters by
the EICP27 protein involved its direct binding to a specific
sequence present within these viral promoters. Our interest
in determining whether the EICP27 protein binds directly to
viral promoters was based on several observations: (i) the
HSV-1 ICP27 and EHV-1 EICP27 proteins possess a
conserved zinc-finger domain within their C-terminal region
(Fig. 1A), (ii) the positions of cysteine and histidine residues
within these alphaherpesvirus zinc-finger domains align
with those present in the sequence for zinc-finger modules
(Rhodes and Klug, 1993), and (iii) zinc-finger domains can
mediate a DNA-binding activity (Kohn et al., 1997; Rhodes
and Klug, 1993). Electrophoretic mobility shift assays
(EMSA) examined whether the EICP27 protein directly
binds to the IE promoter, the early TK, EICP0, and EICP27
promoters, and the late gD and IR5 promoters. Similar
results were obtained for each of the indicated promoters,
and the data presented in Figs. 1B and C depict our findings
with the IE and EICP0 promoters, respectively, and are
representative of the results obtained with the other
indicated early and late promoters. The IE (407–757)
polypeptide served as a positive control as it binds to all
classes of viral promoters (Kim et al., 1995, 2004). In
agreement with our previously published results (Kim et al.,
1995), the EMSA results demonstrated that the IE polypep-
tide bound the IE promoter sequence [151/+65] (Fig. 1B;
lane 8) that contains the pentanucleotide 5V-ATCGT-3V
element (Grundy et al., 1989). Similarly, the IE polypeptide
bound the EICP0 promoter sequence [277/50, relative of
the ATG start codon] (Fig. 1C, lane 8) that contains a
permutation of the pentanucleotide cis-element (Bowles et
al., 1997). GST alone failed to bind to either of the viral
promoter sequences (Figs. 1B and C, lane 2). Unlabeled IE
and EICP0 promoter sequences (Figs. 1B and C; lane 10,
respectively) but not unlabeled SV-Sport-1 sequence (Figs.
1B and C; lane 9) competed for binding of the IE
polypeptide to the probe sequence, which indicated the
specificity of this interaction. Additionally, the anti-IE
protein monoclonal antibody A1.4 (Figs. 1B and C; lane
12), but not the control monoclonal antibody (Figs. 1B and
C; lane 11), generated a super-shifted complex, confirming
the presence of the IE protein at these promoter sequences.
However, purified GST–EICP27 protein failed to exhibit
sequence-specific binding to the IE promoter sequence
(Figs. 1B and C; lanes 3 to 7) as well as to any of the other
Fig. 1. The EICP27 protein is not a sequence-specific DNA-binding protein. (Panel A) Alignment of the zinc-finger domains contained within the EHV-1
EICP27 sequence (aa 414 to 470) and within the HSV-1 ICP27 sequence (456 to 512). The conserved cysteine and histidine residues are denoted by the black
arrows. (Panels B and C) Electrophoretic mobility shift assays examined whether the purified GST-IE (407–757) protein or the purified GST–EICP27 protein
directly bound the 32P-labeled IE promoter [175/+57] (Panel B) or the 32P-labeled EICP0 promoter [277/50, relative of the ATG start codon] (Panel C).
Each reaction contained ~12 ng of either the 32P-labeled IE promoter (Panel B) or the 32P-labeled EICP0 promoter (Panel C). The lane marked Input (lane 1)
lacked any GST protein and served to indicate the position of the 32P-labeled IE promoter and the 32P-labeled EICP0 promoter (Panels B and C, respectively).
The DNA-binding specificity for each GST fusion protein was examined by including ~300 ng of either unlabeled IE promoter or unlabeled EICP0 promoter as
specific competitors (Panels B and C, respectively, lanes 5 and 10) or ~300 ng of an unlabeled sequence derived from the plasmid pSV-Sport1 as a non-specific
competitor (Panels B and C, respectively, lanes 4 and 9). The identity of the IE polypeptide within the DNA–protein complexes was confirmed by including
either the anti-IE protein A1.4 monoclonal antibody (Panels B and C, lane 12, super-shift indicated by the solid arrow) or the negative control anti-Gal4 DNA-
binding domain-specific monoclonal antibody (Panels B and C, lane 11). The inclusion of either the anti-GST–EICP27 polyclonal antibody (Panels B and C, lane
7) or preimmune serum (Panels B and C, lane 6) served to confirm the absence of the EICP27 protein as a component of any DNA–protein complexes.
R.A. Albrecht et al. / Virology 333 (2005) 74–8776four representative early and late EHV-1 promoter sequen-
ces (data not shown).
The EICP27 protein stably associates with the IE protein in
vitro
Transient transfection assays revealed that the EICP27
protein cooperates with the IE and EICP0 proteins to achieve
maximal trans-activation of EHV-1 early and late promoters
(Bowles et al., 2000; Smith et al., 1992; Zhao et al., 1995).
The cooperation between the EICP27 protein and the IE and
EICP0 proteins may involve an interaction of the EICP27
protein with one or both of the EHV-1 regulatory proteins.
GST-pulldown assays initially tested whether the GST–
EICP27 protein precipitated 35S-labeled IE protein, 35S-
labeled E-TIF, and/or 35S-labeled EICP0 protein. The data
presented in Fig. 2A are representative of three independent
experiments and show that the GST–EICP27 protein
efficiently precipitated the IE and EICP0 proteins from in
vitro transcription/translation reactions, but did not effi-
ciently precipitate E-TIF above background levels. GST by
itself as a negative control failed to precipitate any of the 35S-
labeled proteins. Since the EICP0 regulatory protein lacks
DNA-binding activity (S. K. Kim and D. J. O’Callaghan,
unpublished observations, Everett et al., 1993), studies of theEICP27–EICP0 protein interaction would not elucidate
whether the EICP27 protein is recruited to viral promoters.
Therefore, this investigation focused on the EICP27–IE
protein interaction in order to ascertain whether this
interaction resulted in the recruitment of the EICP27 protein
to IE protein-containing preinitiation complexes at viral
promoters. GST-pulldown assays examined the stability of
this EICP27–IE protein interaction in the presence of
increasing concentrations of salt. The data revealed that the
GST–EICP27 protein efficiently precipitated 35S-labeled IE
protein in the presence of salt concentrations ranging from
100 mM to 800 mM (Fig. 2B; lanes 4 to 8). At the 400 mM
salt concentration, the capability of the GST–EICP27 protein
to bind the IE protein was reduced to approximately half of
that observed at the 100 mM salt concentration (Fig. 2B; lane
6 versus lane 4). The 1000 mM salt concentration nearly
abolished the precipitation of the 35S-labeled IE protein by
the GST–EICP27 protein (Fig. 2B; lane 9). GST alone
precipitated only a minimal amount of the labeled IE protein
(Fig. 2B; lane 3). These results suggest that the EICP27
protein stably interacts with the IE protein at salt concen-
trations that exceed physiological conditions by as much as
3-fold. High salt concentrations reportedly weaken electro-
static interactions between proteins, while hydrophobic
associations are enhanced (Tanford, 1961). The decreased
Fig. 2. The EICP27 protein interacts with the IE protein. (Panel A) The GST–EICP27 protein specifically interacts with the IE and EICP0 proteins. GST-
pulldown assays assessed whether the GST–EICP27 protein precipitated 35S-labeled IE, 35S-labeled E-TIF, and/or 35S-labeled EICP0 proteins from IVTT
reactions. (Panel B) GST–EICP27 precipitates the IE protein at high salt concentrations. GST-pulldown assays examined whether the GST–EICP27 protein
precipitated 35S-labeled IE protein from IVTT reactions in the presence of increasing molar concentrations (100 mM to 1000 mM) of salt. For Panels A and B:
(i) the input lanes show the amount of 35S-labeled IE protein in each reaction, in order to estimate the relative binding efficiency of the GST–EICP27 protein,
and (ii) the sizes of the 14C molecular weight markers (kDa) are indicated at the left of the panel. (Panel C) The EICP27 protein is stably synthesized in EHV-1-
infected RK-13 cells. Western blot analysis with the anti-EICP27 antibody confirmed the presence of the EICP27 protein in RK-13 cell extracts prepared at 4
and 9 h post-infection, but not in extracts prepared from mock-infected cells. (Panel D) Co-immunoprecipitation assays demonstrated that the anti-EICP27
antibody co-precipitates the IE protein with the EICP27 protein from infected cell extracts. EICP27–IE protein complexes were co-immunoprecipitated by the
anti-EICP27 protein antibody from cell extracts that were prepared from either mock-infected RK-13 cells or infected cells at 4 or 9 h post-infection. The
presence of the IE protein within the immunoprecipitates was assayed by Western blot analyses with the anti-IE protein antibody.
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suggests that a strong electrostatic interaction mediates the
EICP27–IE protein interaction.
The interplay between the EICP27 and IE proteins was
confirmed by co-immunoprecipitation assays that examined
whether the anti-EICP27 protein antibody co-immunopreci-
pitated the native IE protein with the native EICP27 protein
from EHV-1-infected cell extracts (Fig. 2D). Whole-cell
extracts were prepared from mock-infected RK-13 cells or
from cells infected for 4 h (early) or 9 h (late) with EHV-1.
Western blot analysis confirmed the presence of the native
51.4 kDa EICP27 protein in the virus-infected cell extracts
(Fig. 2C; lanes 3 and 4), and its absence in mock-infected cell
extracts (Fig. 2C; lane 2).Western blot analyses that employed
the anti-IE peptide antibody to detect the IE protein in the co-
immunoprecipitates revealed that the anti-EICP27 protein
antibody co-immunoprecipitated the native IE protein with
the EICP27 protein from virus-infected cell extracts (Fig. 2D;
lanes 8 and 9). The anti-IE peptide antibody did not react with
any cellular proteins that were co-immunoprecipitated fromthe mock-infected cell extracts by the anti-EICP27 protein
antibody (Fig. 2D; lane 7). The negative controls in which
virus-infected cell extracts were incubated with pre-immune
serum failed to precipitate the IE protein (Fig. 2D; lanes 5 and
6). The input lanes contained 10%of the cell extracts thatwere
included in each respective sample, and served to indicate the
amount of the IE protein that was precipitated from the virus-
infected extracts (Fig. 2D; lanes 3 and 4).
The EICP27 protein co-localizes with the IE protein during
EHV-1 infection
To support the data obtained from the GST-pulldown and
co-immunoprecipitation experiments, laser scanning confo-
cal microscopy was conducted to examine the co-localization
of these EHV-1 regulatory proteins in EHV-1-infected cells
(Fig. 3). EHV-1-infected RK-13 cells were incubated with the
anti-EICP27 protein polyclonal antibody and the anti-IE
protein monoclonal antibody A1.4. At early (4 h) and late (9
h) times of infection, the EICP27 protein (green fluorescence)
Fig. 3. Photomicrographs depicting the colocalization of the EICP27 protein with the IE protein. RK-13 cells were either mock-infected or infected with EHV-1
at an MOI of 5 pfu per cell. Infected cells were methanol-fixed at either early (4 h) or late (9 h) times post infection. Colocalization of the EICP27 protein foci
(green) with the IE (1–1487) protein foci (red) is indicated by the yellow foci in the photomicrographs labeled Merge (arrows).
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protein accumulating within foci. The IE protein (red
fluorescence) predominantly localized within discrete nuc-
lear foci at both time points. Merging of the immunofluor-
escence images revealed that some of the EICP27 protein foci
overlapped the IE protein foci within the infected nucleus at
early and late times of infection (yellow foci indicated by the
arrows). Based on the protein–protein interaction data, the co-
localization of the EICP27 and IE proteins in the nuclei of
EHV-1-infected cells is consistent with the data from the
protein–protein interaction assays (Figs. 2A and D) which
showed that these EHV-1 regulatory proteins interact.
IE residues 424 to 826 harbor the EICP27 protein-binding
domain
To delineate the region within the IE protein that mediates
its interaction with the EICP27 protein, GST-pulldown assays
tested the ability of the GST–EICP27 protein to precipitate
35S-labeled truncation and deletion mutant polypeptides of
the full-length IE protein (Fig. 4A). TheGST–EICP27 protein
precipitated the C-terminal truncation mutants IE (1–1254),
IE (1–904), and IE (1–620), but not the mutants IE (1–424)
and IE (1–289) (Fig. 4B). In addition, the GST–EICP27
protein interacted with the N-terminal truncation mutants
IED2–289, IED2–421, IED2–642, and IED2–719, but did notinteract with IED2–826 or IED2–905 (Fig. 4B). These data
indicated that the EICP27 protein-binding domain maps
within IE residues 424 to 826. We next sought to map the
minimal EICP27 protein-binding domain by additional GST-
pulldown assays that tested the ability of the GST–EICP27
protein to precipitate IE derivatives that harbored specific
deletions within the region spanning residues 424 to 826 (Fig.
5A). These results demonstrated that the GST–EICP27
protein efficiently precipitated the full-length 35S-IE protein
and the 35S-IE deletion mutants IED407–757, IED621–757,
and IED644–824 (Fig. 5B). The negative control GST alone
did not precipitate any of these proteins. Overall, these
findings indicate that IE residues 424 to 826 harbor multiple
domains that mediate the IE protein’s interaction with the
EICP27 protein. IE residues 424 to 620 harbor one EICP27
protein-binding domain, while residues 719 to 826 harbor
another domain. The reduced efficiency by which the GST–
EICP27 protein precipitated the IE (1–620) C-terminal
truncation mutant is consistent with this IE mutant harboring
only one of the two EICP27 protein-interactive domains.
EICP27 residues 41 to 206 harbor the IE protein-binding
domain
The region within the EICP27 protein that mediates its
interaction with the IE protein was mapped by GST-
Fig. 4. Mapping the EICP27 protein-binding domain within the IE protein. (Panel A) Schematic representation of the functional domains present within the
full-length and mutant IE polypeptides. The colinear regions R1 to R5 that are conserved among the alphaherpesvirus IE homologues, and the amino acid
positions of the functional domains that contribute to the regulatory functions of the IE protein are illustrated. The amino acid sequence deleted in each
truncation and deletion mutant IE polypeptide is indicated at the left of the figure. The ability of the GST–EICP27 protein to precipitate each radiolabeled IE
polypeptide is indicated at the right of each polypeptide. (Panel B) IE residues 424 to 826 harbor an EICP27 protein-binding domain. GST-pulldown assays
assessed the ability of the GST–EICP27 protein to precipitate the indicated 35S-labeled IE polypeptide from IVTT reactions. The input lanes indicate the
amount of each 35S-labeled IE polypeptide included in each reaction, in order to estimate the relative binding efficiency of the GST–EICP27 protein. The sizes
of the 14C-labeled molecular weight markers (kDa) are indicated at the left of each panel.
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protein to precipitate 35S-radiolabeled truncation and dele-
tion mutants of the full-length EICP27 protein (Fig. 6A).
The GST-IE protein precipitated the radiolabeled EICP27
(1–470), EICP27 (1–281), EICP27D93–140, EICP27D41–
89, EICP27D8–59, EICP27D140–220, and EICP27D216–
446 polypeptides (Fig. 6B). However, the GST–IE fusion
protein failed to precipitate the radiolabeled EICP27 (226–
470) and EICP27D41–279 polypeptides (Fig. 6B). These
observations suggest that EICP27 residues 41 to 279 harbor
one or more domains that mediate its interaction with the IEprotein. Deletions within the EICP27 protein sequence
could result in EICP27 mutants that assume an incorrect
conformation and thus fail to bind to the IE protein as would
the native EICP27 protein. Therefore, additional assays
were performed that examined the ability of GST-fusion
proteins containing portions of EICP27 residues 41 to 282
(Fig. 7A) to precipitate radiolabeled IE protein and thus
elucidate the minimal IE protein-binding domain of the
EICP27 protein. These data would elucidate whether the
inability of the EICP27D41–279 polypeptide to precipitate
the IE protein is attributed to the removal of an IE protein-
Fig. 5. (A) IE residues 407 to 824 mediate an interaction with the EICP27 protein. (B) GST-pulldown assays examined the ability of the GST–EICP27 protein
to precipitate the indicated 35S-labeled IE polypeptide from IVTT reactions. The input lanes indicate the amount of each 35S-labeled IE polypeptide included in
each reaction, in order to estimate the relative binding efficiency of the GST–EICP27 protein. The sizes of the 14C-labeled molecular weight markers (kDa) are
indicated at the left of each panel.
R.A. Albrecht et al. / Virology 333 (2005) 74–8780binding domain or because the polypeptide assumed an
incorrect conformation. These data revealed that the 35S-
labeled IE protein was efficiently precipitated by the full-
length GST–EICP27 fusion protein and by GST fusion
proteins harboring EICP27 residues 41 to 282, 41 to 153,
and 89 to 206 (Fig. 7B, upper autoradiograph). These results
suggest that EICP27 residues 41 to 206 harbor one or more
domains that mediate an interaction with the IE protein.
Previous studies on the regulatory functions of the
EICP27 protein revealed that amino acids 124 to 216
mediate its interaction with TATA box-binding protein
(TBP) (Albrecht et al., 2004). Consistent with our previous
findings, GST fusion proteins harboring the entire EICP27
protein as well as residues 41 to 282, 41 to 153, and 89 to
206 precipitated 35S-labeled TBP (Fig. 7B, lower autoradio-
gram). However, GST alone, the negative control, failed to
precipitate any of the radiolabeled IE protein and precipi-
tated background amounts of radiolabeled TBP. The data
suggest that the same region of the EICP27 protein interacts
with the IE protein and TBP. Therefore, GST-pulldown
assays examined whether EICP27 residues 89 to 206 formed
a tripartite complex with the IE protein and TBP. In these
experiments, the GST–EICP27 (89–206) polypeptide was
examined for its ability to precipitate radiolabeled TBP in
the presence of increasing amounts of either 35S-labeled
luciferase or 35S-labeled IE protein (Fig. 7C). In all reactionsincluding those in which the amount of 35S-labeled IE
protein varied by as much as 20-fold in the presence of a
constant amount of 35S-labeled TBP, the GST–EICP27
polypeptide was able to precipitate similar amounts of 35S-
labeled TBP. The results revealed that the GST–EICP27
(89–206) polypeptide simultaneously precipitated 35S-TBP
and the 35S-IE protein (Fig. 7C; lanes 8 to 10). The GST–
EICP27 polypeptide precipitated only background amounts
of 35S-luciferase (Fig. 7C; lanes 5 and 6). Thus, EICP27
residues 89 to 206 simultaneously interact with the IE
protein and TBP to form a tripartite complex. In addition, in
the presence of increasing amounts of 35S-labeled IE
protein, the GST–EICP27 protein precipitated a constant
amount of IE protein. These data suggest that all of the
available GST–EICP27 interacted with a limiting amount of
35S-labeled IE protein.
The IE protein recruits the EICP27 protein to viral
promoters
Although the EICP27 protein does not directly bind to
viral promoters, its interaction with the IE protein may
allow its recruitment to EHV-1 regulatory sequences. To
address this possibility, EMSAs examined the capacity of
the purified IE (323–1487) polypeptide to recruit the GST–
EICP27 protein to the EHV-1 early EICP27 promoter (Fig.
Fig. 6. Mapping the IE protein-binding domain within the EICP27 protein. (Panel A) Schematic representation of the functional domains present within the
full-length and mutant EICP27 polypeptides. The amino acid positions of the TBP-binding domain, nuclear localization signal, and zinc finger domain that
contribute to the regulatory functions of the EICP27 protein are illustrated. The amino acid sequence present in each EICP27 truncation mutant and deletion
mutant is indicated at the left of the figure. The ability of the GST-IE protein to precipitate each radiolabeled EICP27 polypeptide is indicated at the right of
each polypeptide. (Panel B) EICP27 residues 41 to 216 harbor an IE protein-binding domain. GST-pulldown assays assessed the ability of the GST-IE protein
to precipitate the indicated 35S-labeled EICP27 polypeptide from IVTT reactions. The input lanes indicate the amount of each 35S-labeled EICP27 polypeptide
included in each reaction, in order to estimate the relative binding efficiency of the GST-IE protein. The sizes of the 14C-labeled molecular weight markers
(kDa) are indicated at the left of each panel.
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EHV-1 early EICP0 and late IR5 promoters, and the results
presented for the EICP27 promoter are representative of
findings for all promoters. The results indicated that the IE
polypeptide recognized the 32P-labeled EICP27 promoter
(241/+8) (Fig. 8; lane 4), whereas the EICP27 protein
failed to do so (Fig. 8; lane 3). In the presence of increasing
amounts of the EICP27 protein, the IE protein complex at
the EICP27 promoter migrated more slowly than that
observed for the complex containing the IE polypeptide
alone (Fig. 8; lanes 5 to 7). These data suggest that the
increasing amounts of the GST–EICP27 protein included in
some of the reactions resulted in increased ratios of the
EICP27 protein relative to the limiting amount of IE
protein, hence the generation of DNA–protein complexesof greater molecular size. The inclusion of the anti-IE
(925–943) peptide antibody (Jang et al., 2001) generated a
super-shifted complex, confirming the presence of the IE
protein at this promoter (Fig. 8; lanes 8 and 9). Similarly,
inclusion of the anti-EICP27 protein antibody resulted in a
super-shifted complex, demonstrating the presence of the
EICP27 protein within this complex (Fig. 8; lanes 10 to
13). The negative control GST alone did not bind to the
promoter sequence (Fig. 8; lane 2), and as expected
preimmune serum did not generate a super-shifted complex
(Fig. 8; lane 14). Overall, these results demonstrated that
the EICP27 protein does not physically interact with EHV-
1 promoters, and that the EICP27 protein associates with
viral promoter complexes via its interaction with the IE
protein.
Fig. 7. The EICP27 protein forms a trimeric complex with the IE protein and TBP. (Panel A) Schematic representation of the functional domains present within
the full-length and EICP27 polypeptides that were synthesized as GST fusion proteins. The amino acid sequence present in each EICP27 polypeptide is
indicated at the left of the figure. (Panel B) GST-pulldown assays tested the ability of each GST–EICP27 fusion protein to precipitate either full-length 35S-
labeled IE protein (upper autoradiogram) or full-length 35S-labeled TBP (lower autoradiogram) from IVTT reactions. The input lanes indicate the amount of
either 35S-labeled IE protein or 35S-labeled TBP included in each reaction, in order to estimate the relative binding efficiency of the indicated GST–EICP27
protein. The sizes of the 14C-labeled molecular weight markers (kDa) are indicated at the left of each panel. (Panel C) EICP27 residues 89 to 206
simultaneously co-precipitated the IE protein and TBP. GST-pulldown assays examined the ability of the GST–EICP27 (89–206) polypeptide to co-precipitate
35S-labeled TBP and 35S-labeled IE protein. The amount of 35S-labeled TBP included in each reaction remained constant, whereas some of the samples
included increasing amounts (as much as 20-fold) of 35S-labeled IE protein or 35S-labeled luciferase as indicated. The input lane indicates the amount of 35S-
labeled TBP included in each reaction, which served to monitor the relative binding efficiency of the GST–EICP27 (89–206) polypeptide. The sizes of the 14C-
labeled molecular weight markers (kDa) are indicated at the left of each panel.
Fig. 8. The IE (323–1487) polypeptide physically recruits the EICP27 protein to an early viral promoter. Electrophoretic mobility shift assays that included the
low ionic strength 0.5 tris-boric-EDTA (TBE) buffer that favors the formation of protein–protein interactions at viral promoters tested whether the IE (323–
1487) polypeptide recruited the EICP27 protein to the 32P-labeled EICP27 promoter [241/+8]. The 32P-labeled EICP27 promoter was incubated with the
GST-IE (323–1487) polypeptide alone (lane 4) or with increasing amounts of the GST–EICP27 protein (lanes 5 to 7). The presence of the IE and EICP27
proteins within the protein–DNA complexes was demonstrated by including either the anti-IE (925–943) polyclonal antibody (lanes 8 and 9), the anti-GST–
EICP27 polyclonal antibody (lanes 10 to 13), or preimmune serum in some reactions (lane 14). The lane marked No Protein (lane 1) lacked GST protein and
served to indicate the position of the 32P-labeled EICP27 promoter.
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Previous work on EHV-1 gene regulation demonstrated
that the EICP27 protein cooperates with either the IE protein
or EICP0 protein, resulting in the synergistic trans-activation
of EHV-1 promoters (Bowles et al., 2000; Smith et al., 1992,
1993; Zhao et al., 1995). However, these experiments did not
address the mechanism(s) by which the EICP27 protein
contributes to the trans-activation functions of the IE and
EICP0 proteins. Although the EICP27 protein lacks a trans-
activation domain, residues 124 to 220 of the EICP27 protein
mediate an interaction with the cellular transcription factor
TBP (Albrecht et al., 2004).
In this manuscript, in vitro protein binding studies
revealed that the IE and EICP0 proteins, but not ETIF, are
interactive partners of the GST–EICP27 protein. The
EICP27–EICP0 protein interaction is consistent with our
prior observations that these two regulatory proteins
cooperate to synergistically trans-activate EHV-1 early and
late viral promoters (Bowles et al., 2000). The current EMSA
studies on the EICP27 protein and previous studies of the
EICP0 protein revealed that these EHV-1 proteins are
incapable of directly binding to viral promoter sequences
in a sequence-specific manner (S. K. Kim and D. J.
O’Callaghan, unpublished observations, Everett et al.,
1993). Considering these observations, it remains to be
ascertained how the EICP27 and EICP0 proteins specifically
stimulate EHV-1 promoters and whether the physical
interaction between these proteins influences their activation
of viral promoters.
The IE–EICP27 protein interaction was examined more
extensively because this association may elucidate one
mechanism by which the EICP27 protein is specifically
incorporated into preinitiation complexes assembling at
viral promoters. The binding of these EHV-1 proteins in
the presence of high salt concentrations (400 mM NaCl)
indicated the stability of this association. The IE protein-
binding domain mapped within a region of the EICP27
protein (aa 41 to 206) that also contains a NLS and
harbors a TBP-binding domain (Albrecht et al., 2004). The
EICP27 protein-binding domain was mapped to a region of
the IE protein (aa 424 to 826) that harbors its binding
domains for DNA, TFIIB, and the EICP0 protein (Jang et
al., 2001; Kim et al., 2003, 1995). An antagonistic
relationship exists between the IE and EICP0 proteins that
may be mediated by the physical association of these two
EHV-1 regulatory proteins during infection (Kim et al.,
2003). Since the EICP27 and EICP0 proteins may compete
for binding to the same region of the IE protein, the
EICP27–IE protein interaction may perturb the ability of
the IE protein to antagonize the regulatory functions of the
EICP0 protein. One consequence of the interaction
between EICP27 and IE proteins is that the EICP27
protein associates with viral promoter complexes. In
addition, the EICP27 protein forms a tripartite complex
with the IE protein and TBP, a finding that is consistentwith our hypothesis that this early regulatory protein is
incorporated into IE protein-governed preinitiation com-
plexes. Spengler et al. (2000) also demonstrated a physical
interaction between the varicella-zoster virus IE4 and IE62
proteins. However, the authors did not map the IE62
protein-binding domain within the IE4 protein and did not
examine whether the interaction of the IE4 protein with the
IE62 protein resulted in the recruitment of the IE4 protein
to viral promoter complexes.
Our speculation that the EICP27 protein regulates tran-
scription is consistent with several findings of the HSV-1
immediate-early ICP27 protein. Panagiotidis et al. (1997)
demonstrated by gel shift assays that HSV-1 ICP27
associated with protein complexes at viral promoters,
possibly due to its interaction with the HSV-1 ICP4 protein.
Jenkins and Spencer (2001) demonstrated the presence of
ICP27 within RNA polymerase II holoenzyme complexes
that were devoid of TFIIE. Co-immunoprecipitation studies
showed an association of this HSV-1 protein with RNA
polymerase II, suggesting one mechanism by which ICP27
incorporates within preinitiation complexes (Zhou and
Knipe, 2002). Interactions of ICP27 with RNA polymerase
II factors may explain how this HSV-1 regulatory protein
increases transcription of late genes (Jean et al., 2001) and
expression of viral genes encoding proteins necessary for
replication of the viral genome (McCarthy et al., 1989; Rice
and Knipe, 1990; Rice et al., 1989; Sacks et al., 1985;
Uprichard and Knipe, 1996). Lastly, HSV-1 ICP27 is
present within ND10 structures that serve as sites for viral
genomic replication and transcription (Everett et al., 2004;
Tang et al., 2003; Zhong and Hayward, 1997). Together,
these observations suggest that this protein is incorporated
within an RNA polymerase II preinitiation complex;
however, few studies have elucidated exactly how these
protein interactions involving HSV-1 ICP27 contribute to
transcription of viral genes.
The functions of HSV-1 ICP27 in post-transcriptional
processes have been investigated, and the findings from
several laboratories were discussed in a recent review
(Sandri-Goldin, 2004). These studies revealed that ICP27:
(i) binds viral transcripts; (ii) regulates the processing of the
3V ends of pre-mRNA; (iii) shuttles between the nucleus and
cytoplasm, (iv) facilitates the nuclear export of viral intron-
less transcripts; (v) inhibits splicing of intron-containing
pre-mRNA; and (vi) influences the intranuclear distribution
of small nuclear ribonucleoproteins. Whether the EHV-1
EICP27 protein, which is an early gene product that
exhibits limited homology with its HSV-1 counterpart,
mediates any of these post-transcriptional functions remains
to be determined.
The prior observation that the EICP27 protein interacts
with TBP (Albrecht et al., 2004) combined with the
findings presented here that this early viral protein is
physically recruited to viral promoters by its interaction
with the IE protein are consistent with our hypothesis that
the EICP27 protein actively participates within RNA
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ation of the EICP27 and IE proteins influences the
interactions of the IE protein with additional viral and/or
cellular transcription factors will be addressed in future
studies. Other questions to be addressed are whether the
EICP27 protein contributes to the assembly and stability of
preinitiation complexes at viral promoters, and whether the
EICP27 protein stimulates transcription elongation by RNA
polymerase II.Materials and methods
Virus and cell culture
The propagation of EHV-1 (KyA strain) in murine
fibroblast L-M cells and the plaque assays to titer EHV-1
were described previously (Perdue et al., 1974). The
propagation of L-M cell as suspension cultures in YELP
medium and rabbit kidney cells (RK-13 cells; ATCC CCL
37) in EMEM was described elsewhere (Albrecht et al.,
2004).
Cloning of expression plasmids
The procedures for cloning the expression plasmids
employed in this investigation were outlined elsewhere
(Sambrook et al., 1989). DNA sequencing to confirm that
the indicated coding sequences were cloned in-frame into the
expression plasmids employed the Thermo Sequenase
Radiolabeled Terminator Cycle Sequencing kit (USB Cor-
poration, Cleveland, OH) per the manufacturer’s directions.
Some plasmids were sequenced by the DNA Laboratory at
Arizona State University, Tempe, AZ.
Bacterial expression plasmids
pGexEICP27 (1–470) that harbors the EICP27 open
reading frame (ORF) cloned in-frame with the sequence
encoding GST was described previously (Albrecht et al.,
2004). pGexEICP27 (41–282) was created by digesting
pSVEICP27in41 (Albrecht et al., 2004) with BglII and
HindIII, and ligating the released fragment into pGex-Kg
(Guan and Dixon, 1991) that was digested with BamHI and
HindIII. pGexEICP27 (41–153) was created by digesting
the pSVEICP27in41 with BglII and SacI, and ligating the
released fragment with pGexKg that was digested with
BamHI and SacI. pGexEICP27 (89–206) was created by
digesting pSVEICP27in89 (Albrecht et al., 2004) with BglII
and NotI, and cloning the released fragment into pGex4T-2
(Amersham Biosciences, Piscataway, NJ) that was digested
with BamHI and NotI. Plasmids pGexIE (1–1487), pGexIE
(407–757) and pGexIE (323–1487) in which the indicated
coding sequence of the IE gene is cloned in-frame with the
sequence encoding GST were detailed earlier (Jang et al.,
2001; Kim et al., 1995).In vitro transcription/translation expression plasmids
pGemEICP0 that expresses the entire EICP0 gene and
pGemTBP that expresses the TBP gene were described
earlier (Albrecht et al., 2004; Bowles et al., 1997).
pGemETIF that expresses the ETIF gene was created by
subcloning the HindIII–XbaI fragment of pCETIF (Kim and
O’Callaghan, 2001) into the same sites of pGem3z
(Promega Corporation, Madison, WI). pG3IE (1–1487),
pG3IE (1–1254), pG3IE (1–904), pG3IE (1–620), pG3IE
(1–424), pG3IE (1–289), pG3IED2–289, pG3IED2–421,
pG3IED2–654, pG3IED2–719, pG3IED2–826, pG3IED2–
905, pG3IED407–757, pG3IED621–757, and pG3IED644–
824 that express the indicated IE coding sequence were
described previously (Jang et al., 2001). Plasmids pGe-
mEICP27(1–470), pGemEICP27(1–281), pGemEICP27D8–
59, pGemEICP27D41–89, pGemEICP27D93–140, and
pGemEICP27D140–220 that express the indicated EICP27
codons were described previously (Albrecht et al., 2004).
pGemEICP27D41–279 and pGemEICP27D216–446 were
generated by subcloning the EcoRI–SphI fragment of
pSVEICP27D41–279 and pSVEICP27D216–446, respec-
tively (Albrecht et al., 2004), into the same sites of pGem3z.
pGemEICP27(226–470) was created by digesting
pSVEICP27 (Albrecht et al., 2004) with NotI and SphI and
cloning the resulting fragment into the same sites of pGem5z
(Promega).
Laser scanning confocal microscopy
RK-13 cell monolayers of 2  104 cells per well of two-
well Lab-Tek chamber slides (Nagle Nunc International,
Naperville, IL) were either mock-infected or infected with
EHV-1 at anMOI of 5 pfu per cell. At early (4 h) and late (9 h)
times post-infection, the cells were fixed onto the glass slides
with 100% ice-cold methanol for 10 min. The slides were
washed 3 times with phosphate buffered saline (PBS) for 10
min per wash and then incubated with the primary antibodies
anti-GST–EICP27 polyclonal antibody (Albrecht et al.,
2004; antibody diluted 1:1000 in PBS) and anti-IE mono-
clonal A1.4 antibody (Caughman et al., 1995; antibody
diluted 1:200) for 1 h. Following 3 washes with PBS, the
slides were incubated with the secondary antibody FITC-
conjugated goat anti-rabbit IgG antibody or TRITC-con-
jugated goat anti-mouse IgG antibody for 1 h. After 3 washes
with PBS, the slides were mounted with a solution of 50%
glycerol and 0.1% p-phenylenediamine in PBS. Images were
obtained with a laser scanning confocal microscope system
(MRC600; Bio-Rad Laboratories, Hercules, CA) attached to
a Nikon Diaphot microscope as described previously
(O’Callaghan et al., 1994).
Expression and purification of GST fusion proteins
The expression and purification of GST-fusion proteins
have been described elsewhere (Albrecht et al., 2003; Kim et
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pLysE (Novagen, Madison, WI) or trxB(DE3)pLysE (Nova-
gen) were employed for induction of GST-fusion protein
synthesis. Antibiotic selection involved 100 Ag ampicillin
per ml and either 50 Ag kanamycin per ml for the
trxB(DE3)LysE strain or 25 Ag chloramphenicol per ml for
the BL21(DE3)pLysE strain. The methods for desalting and
for ascertaining the concentration of the purified GST-fusion
proteins were described elsewhere (Jang et al., 2001). The
purified GST–IE protein and the GST–EICP27 protein were
centrifuged through 100 kDa and 50 kDa Centricon size
exclusion spin columns (Millipore, Bedford, MA), respec-
tively, to separate the majority of the proteolytic/degradation
products from the full-length GST fusion proteins.
In vitro transcription/translation reactions
The Sp6 promoter controlled expression of the ETIF,
EICP0, IE, and TBP pGem expression plasmids, while the T7
promoter controlled expression of the EICP27 pGem
expression plasmids. In vitro transcription/translation (IVTT)
reactions were performed with the TnT quick-coupled rabbit
reticulocyte lysate system (Promega, Madison, WI) accord-
ing to the manufacturer’s directions. 35S-labeled proteins
were synthesized by including [35S]methionine (40 ACi/ml;
specific activity, 1175 Ci/mmol; New England Nuclear
Corporation, Boston, MA) in the IVTT reactions. Synthesis
of the 35S-labeled proteins was checked by SDS-PAGE
analysis and autoradiography.
GST-pulldown assays
GST-pulldown assays that employed 35S-labeled poly-
peptides were performed as detailed previously (Albrecht et
al., 2003). Briefly, 2 Ag of either GST alone or the indicated
GST fusion protein were mixed with 35S-labeled proteins in
600 Al of NETN buffer. The 35S-labeled proteins precipitated
by the GST fusion protein were analyzed by SDS-PAGE
followed by autoradiography using phosphorstorage screens
(Molecular Dynamics, Amersham Biosciences, Piscataway,
NJ). The 35S-labeled proteins were visualized by analyzing
the screens in the Storm phosphorimager (Molecular
Dynamics) or the Molecular Imager FX system (Bio-Rad
Laboratories, Hercules, CA).
Co-immunoprecipitation assays
To confirm the data obtained from the GST-pulldown
assays, co-immunoprecipitation assays were performed as
described elsewhere (Albrecht et al., 2004). Briefly, 5  106
L-M cells were either mock-infected or infected with EHV-1
at an MOI of 10 plaque forming units per cell. At 4 and 9 h
post-infection, whole cell extracts were prepared by
precipitating the cells by centrifugation and lysing the cells
in lysis buffer (1% Triton X-100, 50 mM Tris–HCl [pH 7.4],
300 mM NaCl, 5 mM EDTA, and 0.02% sodium azide). Theprotein concentration of each sample was determined with
the BCA kit (Pierce Endogen, Rockford, IL). Each co-
immunoprecipitation reaction included 200 Ag of cell
extract incubated with 2 Al of either pre-immune serum or
anti-GST–EICP27 protein antibody in 600 Al of immuno-
precipitation buffer (Albrecht et al., 2004). After processing
the reactions as detailed previously (Albrecht et al., 2004),
the pelleted protein A agarose beads containing the co-
immunoprecipitated protein complexes were resuspended in
2 Laemmli buffer (Sigma, St. Louis, MO) and subjected to
Western blot analysis with the anti-IE peptide antibody
(Albrecht et al., 2003).
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays were performed
essentially as described (Kim et al., 1995). The 32P-labeled
probe harboring the IE promoter sequence [175/+57,
relative to the transcription initiation site] was generated by
PCR amplification with the forward primer IEgsaF 5V-
AAAGCGCATGCAAATGCAAAGCGCGGGACC-3V and
reverse primer IEgsaR 5V-ATAGTCCTCGAAGGCTG-
GCTGG-3V and plasmid pIE [802/+73]-CAT. The 32P-
labeled probe harboring the EICP0 promoter sequence
[277/50, relative of the ATG start codon] was generated
by PCR amplification. The PCR reactions consisted of
plasmid pEICP0 [339/21]-CAT (Kim et al., 2004), the
forward primer EICPOFP 5V-AACCACCGTGTGCT-
CACCCG-3V, and the reverse primer EICP0RP 5V-
TTAAAACCAGGCTTGGTGCC-3V. The 32P-labeled probe
harboring the EICP27 promoter sequence [241/+8] was
generated by PCR amplification. The PCR reactions con-
sisted of plasmid pXbaI-G (Zhao et al., 1992), the forward
primer RAE27FP 5V-AACCCCCCGACTCCCG-3V, and
reverse primer 5V-GCCAAGAGTGCGGACC-3V. The DNA
fragments were end-labeled with [g-32P]dATP (New England
Biolabs, Beverly, MA) and T4 polynucleotide kinase
(Promega). The DNA-binding reactions contained approx-
imately 20,000 CPM of radiolabeled DNA probe (approx-
imately 12 ng), 1.5 Ag of poly[dI-dC] as a nonspecific
competitor, 50 or 100 ng of the indicated protein in 20 Al of
binding buffer (10 mM Tris–HCl [pH 7.5], 1 mM EDTA, 10
mMmercaptoethanol, 0.1% (wt/vol) CHAPS, 100mMNaCl,
10% glycerol). DNA–protein complexes were allowed to
assemble for 30 min at room temperature. The non-specific
competitor DNA was isolated by PCR amplification of the
pSV-Sport1 sequence spanning bp 1378 to 1618 with the
forward primer 5V-CTGTTCCGACCCTGCCGC-3V and the
reverse primer 5V-TGGCTGCTGCCAGTGGCG-3V. To con-
firm the presence of the IE protein within DNA–protein
complexes, either the anti-IE protein monoclonal antibody
A1.4 or the anti-IE (925–943) polyclonal antibody was
included in some reactions. The presence of the EICP27
protein was demonstrated by including the anti-GST–
EICP27 protein polyclonal antibody in some reactions. The
control antibodies included the anti-Gal4 DNA-binding
R.A. Albrecht et al. / Virology 333 (2005) 74–8786domain-specific monoclonal antibody (RK5C1, Santa Cruz
Biotech, Santa Cruz, CA) and rabbit preimmune serum. In the
antibody-containing reactions, the indicated antibody was
added after the initial 30-min incubation, and the sample was
incubated an additional 30 min. Following the incubation
period, the DNA–protein complexes were resolved by
polyacrylamide gel electrophoresis at 20 mAmps in a non-
denaturing gel containing 4% acrylamide/bis-acrylamide,
10% glycerol and either 0.5 TBE buffer (10 stock
solution: 89 mM Tris base, 89 mM boric acid, 20 mM
EDTA, and 25 mMMgCl2) or 0.75 TGE buffer (10 stock
solution: 25 mMTris base, 1.9M glycine, 10mMEDTA, and
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